Evaluation of efficacy and tolerability of switching to ziprasidone from other antipsychotic medications

Trial Profile

Evaluation of efficacy and tolerability of switching to ziprasidone from other antipsychotic medications

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Aug 2015

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 May 2008 Status changed from in progress to completed.
    • 22 Oct 2007 The expected completion date for this trial is now 1 Dec 2008.
    • 17 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top